Forbes: Randomized Control Testing: A Science Being Tested To Measure An Advertiser’s ROI

By Brad Adgate

The ability to measure the impact advertising has on sales has been the holy grail for marketers, agencies and data scientists. It dates back to John Wanamaker (1838-1922), who has been credited with the adage, “Half the money I spend on advertising is wasted; the trouble is I don't know which half”. Since then, with more ad supported media choices and more brands, consumers have been bombarded by ad messages daily. Meanwhile, advertisers continue to seek better ways to measure the sales impact from their media campaigns.

Attempting to measure the return-on-investment (ROI) of an ad campaign is not new. In the 1990s some prominent advertisers, including Procter & Gamble, began using media mix modeling (MMM) to measure the ROI of their ad campaigns. Although the media landscape was far less complex than today, MMM had several inadequacies including; not enough data points and it did not factor either the consumer journey or brand messaging. Nonetheless, MMM remained an industry fixture for many advertisers and agencies. Other marketers used recall and awareness studies as a substitute for sales to measure the advertising impact.

In July, the Advertising Research Foundation (ARF) began a new initiative called RCT21, (RCT stands for Randomized Control Testing), the latest iteration of measuring an ad campaign’s impact on sales. In the press release the ARF stated they “Will apply experimentation methods to measure incremental ROI of large ad campaigns run across multiple media channels at once, including addressable, linear TV and multiple major digital media platforms.”

Full article on Forbes.com